These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2274472)

  • 1. Methotrexate binding to human plasma proteins.
    Skibińska L; Ramlau C; Załuski J; Olejniczak B
    Pol J Pharmacol Pharm; 1990; 42(2):151-7. PubMed ID: 2274472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
    Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
    Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein binding of indomethacin, methotrexate and morphine in patients with cancer.
    Raveendran R; Heybroek WM; Caulfield M; Abrams SM; Wrigley PF; Slevin M; Turner P
    Int J Clin Pharmacol Res; 1992; 12(3):117-22. PubMed ID: 1473877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response.
    Benz C; DeGregorio M; Saks S; Sambol N; Holleran W; Ignoffo R; Lewis B; Cadman E
    Cancer Res; 1985 Jul; 45(7):3354-8. PubMed ID: 4005858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene attenuation of methotrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-FU/methotrexate.
    Das JR; Fryar EB; Epie NN; Southerland WM; Bowen D
    Anticancer Res; 2006; 26(3A):1877-83. PubMed ID: 16827120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo protein binding of methotrexate assessed by microdialysis.
    Maia MB; Saivin S; Chatelut E; Malmary MF; Houin G
    Int J Clin Pharmacol Ther; 1996 Aug; 34(8):335-41. PubMed ID: 8864795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
    Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
    Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
    Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy for recurrent breast carcinoma].
    Taguchi T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):439-47. PubMed ID: 4004279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of human serum albumin binding of methotrexate by folinic acid and certain drugs used in cancer chemotherapy.
    Coassolo P; Valentin M; Bourdeaux M; Briand C
    Eur J Clin Pharmacol; 1980 Feb; 17(2):123-7. PubMed ID: 6966221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of concomitant aspirin or prednisone on methotrexate synovial fluid concentration.
    Stewart CF; Christensen ML; Evens RP; Cremer M; Evans WE
    J Pharmacol Exp Ther; 1987 Oct; 243(1):131-7. PubMed ID: 3668846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline protein binding.
    Trnavská Z
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):166-9. PubMed ID: 2334456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity binding of ochratoxin A to plasma constituents.
    Stojković R; Hult K; Gamulin S; Plestina R
    Biochem Int; 1984 Jul; 9(1):33-8. PubMed ID: 6477636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate serum binding in rheumatoid arthritis.
    Claudepierre P; Urien S; Chevalier X; Chassany O; Larget-Piet B; Tillement JP
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):113-5. PubMed ID: 8205370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
    Kano Y; Ohnuma T; Okano T; Holland JF
    Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study.
    Kaye SB; Sangster G; Hutcheon A; Habeshaw T; Crossling F; Ferguson C; McArdle C; Smith D; George WD; Calman KC
    Cancer Treat Rep; 1984 Mar; 68(3):547-8. PubMed ID: 6704984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.